These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2570173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J, Nabata H, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of prazosin on the guinea-pig ileum.
    Fagbemi SO, Salako LA.
    Br J Pharmacol; 1980 Nov; 70(3):395-402. PubMed ID: 6108144
    [Abstract] [Full Text] [Related]

  • 8. A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins.
    Shoji T, Tsuru H, Shigei T.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):246-55. PubMed ID: 6141530
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of the postsynaptic alpha-adrenoceptors in isolated canine mesenteric arteries and veins.
    Itoh H, Kohli JD, Rajfer SI.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):44-9. PubMed ID: 2883585
    [Abstract] [Full Text] [Related]

  • 13. Noradrenaline-induced contraction of human saphenous vein and human internal mammary artery: involvement of different alpha-adrenoceptor subtypes.
    Giessler C, Wangemann T, Silber RE, Dhein S, Brodde OE.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):104-9. PubMed ID: 12122495
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K, Baba A, Akima M, Koga T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1989 Aug; 299():169-84. PubMed ID: 2570554
    [Abstract] [Full Text] [Related]

  • 16. Relation between alpha 1-adrenoceptor subtypes and noradrenaline-induced contraction in rat portal vein smooth muscle.
    Sayet I, Neuilly G, Rakotoarisoa L, Mironneau C, Mironneau J.
    Br J Pharmacol; 1993 Sep; 110(1):207-12. PubMed ID: 8106102
    [Abstract] [Full Text] [Related]

  • 17. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    Shibata S, Satake N, Suh TK, Ishida Y, Ueda S, Follmer C, Flores F.
    Gen Pharmacol; 1986 Sep; 17(2):143-9. PubMed ID: 2870954
    [Abstract] [Full Text] [Related]

  • 18. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Aono J, Sakai K.
    Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
    [Abstract] [Full Text] [Related]

  • 19. Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery.
    von Kügelgen I, Starke K.
    J Physiol; 1985 Oct; 367():435-55. PubMed ID: 2865364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.